A carregar...
A missed opportunity – consequences of unknown levetiracepam pharmacokinetics in a peritoneal dialysis patient
BACKGROUND: Levetiracetam is a frequently used drug in the therapy of partial onset, myoclonic and generalized tonic-clonic seizures. The main route of elimination is via the kidneys, which eliminate 66% of the unchanged drug as well as 24% as inactive metabolite that stems from enzymatic hydrolysis...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4006077/ https://ncbi.nlm.nih.gov/pubmed/24739070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-15-49 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|